GSK plc Stock price Deutsche Boerse AG

Equities

GS71

GB00BN7SWP63

Pharmaceuticals

Delayed Deutsche Boerse AG 04:50:04 2024-03-28 pm EDT 5-day change 1st Jan Change
19.85 EUR +1.50% Intraday chart for GSK plc +2.99% +18.95%

Financials

Sales 2024 * 31.54B 39.84B 36.89B Sales 2025 * 33.44B 42.25B 39.12B Capitalization 69.81B 88.19B 81.66B
Net income 2024 * 5.6B 7.08B 6.56B Net income 2025 * 6.25B 7.9B 7.31B EV / Sales 2024 * 2.61 x
Net Debt 2024 * 12.51B 15.81B 14.64B Net Debt 2025 * 9.38B 11.85B 10.97B EV / Sales 2025 * 2.37 x
P/E ratio 2024 *
12.5 x
P/E ratio 2025 *
11 x
Employees 70,212
Yield 2024 *
3.59%
Yield 2025 *
3.88%
Free-Float 92.08%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.50%
1 week+2.99%
Current month+1.76%
1 month+2.33%
3 months+20.35%
6 months+16.30%
Current year+18.95%
More quotes
1 week
19.42
Extreme 19.418
19.90
1 month
19.00
Extreme 19.004
20.12
Current year
16.48
Extreme 16.482
20.12
1 year
15.24
Extreme 15.242
20.12
3 years
14.62
Extreme 14.62
27.13
5 years
14.62
Extreme 14.62
27.52
10 years
14.62
Extreme 14.62
28.69
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 10-04-30
Director of Finance/CFO 62 23-04-30
Compliance Officer - 95-07-31
Members of the board TitleAgeSince
Director of Finance/CFO 62 23-04-30
Chairman 66 19-08-31
Director/Board Member 65 14-12-31
More insiders
Date Price Change Volume
24-03-28 19.85 +1.50% 890
24-03-27 19.55 +0.35% 477
24-03-26 19.48 -0.59% 1,668
24-03-25 19.6 +0.84% 2,425
24-03-22 19.44 +0.86% 560

Delayed Quote Deutsche Boerse AG, March 28, 2024 at 04:50 pm EDT

More quotes
GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed monoclonal antibodies to help treat different diseases. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes more than 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines include medicines for immune-mediated conditions. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
17.09 GBP
Average target price
19.63 GBP
Spread / Average Target
+14.90%
Consensus
  1. Stock
  2. Equities
  3. Stock GSK plc
  4. Stock GSK plc - Deutsche Boerse AG